Mitoxantrone Hydrochloride (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Mitoxantrone Hydrochloride drug offered from Pfizer Laboratories Div Pfizer Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
NON-PROPRIETARY NAME: | Mitoxantrone Hydrochloride |
SUBSTANCE NAME: | MITOXANTRONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-12-12 |
END MARKETING DATE: | 0000-00-00 |
Mitoxantrone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Mitoxantrone Hydrochloride from Pfizer Laboratories Div Pfizer Inc. |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2012-12-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0080_5815a273-349f-4a9b-b6fd-af44958ba67c |
PRODUCT NDC: | 0069-0080 |
APPLICATION NUMBER: | ANDA201014 |
Other MITOXANTRONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: